Care Home Managers are recommended to proactively support the MRHA Yellow Care scheme.

Health and Social care providers, including doctors, nurses, pharmacists, and other healthcare professionals, play a crucial role in the Medicines and Health care products Regulatory Agency (MHRA) Yellow Card Scheme. Reporting adverse reactions and side effects to the scheme helps ensure the safety of medications and medical devices.


Here’s how care provides can engage in the MHRA Yellow Card Scheme:

Awareness and Education:

Ensure that you and your healthcare team are aware of the Yellow Card Scheme and its importance in pharmacovigilance.

Stay updated on the latest guidance and information provided by the MHRA regarding the reporting of adverse reactions.


Identifying Adverse Reactions:

Regularly monitor your residents for any signs of adverse reactions or unexpected side effects related to the medications they are taking.

Be attentive to new or unusual symptoms, changes in resident’s condition, or any concerns raised by the resident.


Gather Relevant Information:

When you identify a potential adverse reaction, gather comprehensive and accurate information about the patient, the medication, and the reaction itself.

Include details such as the name of the medication, batch number (if available), strength, dosage form, patient’s age, gender, medical history, onset of symptoms, severity, duration, and any medical interventions undertaken.


Report to the Yellow Card Scheme:

Access the Yellow Card Scheme online through the official MHRA website.

Fill out the Yellow Card report form, providing all the relevant information you have collected.

Submit the report to the MHRA. If you have an account, you can track and manage your reports more easily.


Encourage Resident Involvement:

Inform your residents about the Yellow Card Scheme and encourage them to report any adverse reactions they experience directly if they are comfortable doing so.


Collaboration and Communication:

Share your findings and experiences related to adverse reactions with your colleagues and healthcare networks to promote awareness and learning.


Follow-Up and Further Information:

Be prepared to provide additional information or respond to inquiries from the MHRA if they require more details about a reported adverse reaction.


Stay Informed:

Continuously update your knowledge about the Yellow Card Scheme and any changes to reporting procedures or guidelines.


Remember, the primary goal of the Yellow Card Scheme is to improve patient safety by collecting and analyzing information about adverse reactions. By actively participating in the scheme, healthcare providers contribute to the ongoing monitoring and assessment of medication safety.


For the most current and accurate guidance on how care providers should engage in the MHRA Yellow Card Scheme, please refer to the official MHRA website or contact the MHRA directly.


The Team at Swift Management Services are committed to Quality and Safety within Health and Social Care Settings. To find out more about how we can help, visit our website at or call us on 020 8087 2072 to speak to one of our advisors